| About the author: |
V. O. Romanova, N. V. Kuzminova, A. V. Ivankova, S. E. Lozinsky, I. I. Kniazkova, O. L. Poberezhets, M. V. Repetenko |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
To evaluate the prognostic significance of markers of nonspecific systemic inflammation as predictors of unfavorable prognosis in patients with coronary heart disease, data from 135 patients with uncomplicated disease and 27 with unfavorable outcomes were analyzed. A 2-year prospective study showed that unfavorable cardiovascular events were significantly more common in patients with coronary heart disease and elevated levels of biomarkers of nonspecific systemic inflammation compared with those with lower values. The presence of myocardial infarction at baseline, a decrease in left ventricular ejection fraction <50 %, and increased levels of markers of nonspecific systemic inflammation such as C-reactive protein, determined by a highly sensitive method, and tumor necrosis factor-α had significant predictive value for the likelihood of unfavorable events. |
| Tags |
coronary heart disease,patient prognosis,nonspecific systemic inflammation,high-sensitivity C-reactive protein,tumor necrosis factor-α,fibrinogen,blood lipids,atherosclerosis |
| Bibliography |
- Kovalenko VM, Kornatskyy VM, editors. Aktualni problemy zdorovya ta minimizatsiya yikh v umovakh zbroynoho konfliktu v Ukrayini: posibnyk. Kyyiv: Derzhavna ustanova «Natsionalnyy naukovyy tsentr «Instytut kardiolohiyi imeni akademika M.D.Strazheska»; 2018. [in Ukrainian]
- 2013 ESC guidelines on the management of stable coronary artery disease. European Heart Journal. 2013;34(38):2949–3003. doi:10.1093/eurheartj/eht296
- Braunwald E. Creating controversy where none exists: The important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. European Heart Journal. 2011 Sept 6;33(4):430–2. doi:10.1093/eurheartj/ehr310
- Cacko A, Kondracka A, Gawałko M, Główczyńska R, Filipiak KJ, Bartoszewicz Z, et al. Novel biochemical predictors of unfavorable prognosis for stable coronary disease. Medicine. 2018;97(37). doi: 10.1097/md.0000000000012372
- Crea F, Libby P. Acute coronary syndromes. Circulation. 2017;136(12):1155–66. doi: 10.1161/CIRCULATIONAHA.117.029870
- Cui Z, Zhao G, Liu X. Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Medicine. 2022;101(33). doi: 10.1097/md.0000000000030117
- De Caterina R, D’Ugo E, Libby P. Inflammation and thrombosis – testing the hypothesis with anti-inflammatory drug trials. Thrombosis and Haemostasis. 2016;116(12):1012–21. doi: 10.1160/th16-03-0246
- Hou Y, Carrim N, Wang Y, Gallant RC, Marshall A, Ni H. Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin mediated protein wave of hemostasis. The Journal of Biomedical Research. 2015;29(6):437–44. doi:10.7555/jbr.29.20150121
- Lindstrom M, DeCleene N, Dorsey H, et al. Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021. J Am Coll Cardiol. 2022 Dec, 80 (25) 2372–2425
- Ridker PM. Residual inflammatory risk: Addressing the obverse side of the Atherosclerosis Prevention Coin. European Heart Journal. 2016 Feb 22;37(22):1720–2. doi:10.1093/eurheartj/ehw024
- Romanova VO, Kuzminova NV, Romanova LO, Lozinsky SE, Knyazkova II, Kulchytska OM, et al. Indicators of nonspecific systemic inflammation as criteria for destabilization of the course of coronary artery disease. World of Medicine and Biology. 2022;18(82):153. doi:10.26724/2079-8334-2022-4-82-153-157
- Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, et al. Epidemiology of Cardiovascular Disease in Europe. Nature Reviews Cardiology. 2021;19(2):133-43. doi: 10.1038/s41569-021-00607-3
- Urschel K, Cicha I. TNF-Α in the cardiovascular system: From physiology to therapy. International Journal of Interferon, Cytokine and Mediator Research. 2015; 7:9–25. doi: 10.2147/ijicmr.s64894
- Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circulation Research. 2019;124(2):315–27. doi: 10.1161/circresaha.118.313591a
|
| Publication of the article |
«World of Medicine and Biology» №2(88), 2024 year, 129-133 pages, index UDK 616.13-002:616.12-005.4-08 |
| DOI |
10.26724/2079-8334-2024-2-88-129-133 |
